Connect with us

Prescription Drugs

Warning Required for Asthma and Allergy Medication

mm

Published

on

The medication for asthma and allergies, montelukast, will now require a boxed warning, according to the US Food and Drug Administration. This medication is better known as Singulair.

The Black Box Warning

The boxed warning is the most prominent warning given by the FDA. For this medication, it warns health care providers not to give the medication to patients who are only exhibiting mild symptoms of asthma or allergies. An existing warning is also being made stronger, which links the medication with a higher risk of neuropsychiatric events. These may include depression, agitation and thoughts of suicide, along with an increased risk for actions behind those thoughts.

The FDA says that many health care providers and their patients aren’t aware of the risks associated with Singulair. An updated medication guide is also being given out when patients get a prescription for montelukast.

The medication has been in use since its approval in 1998. The FDA re-evaluated the benefits of montelukast along with the risks and compared them to other treatments. Based on findings, the FDA has decided the risks could outweigh any advantages. The agency recommends prescribing the medication only if other treatments have failed or if the patient cannot tolerate them.

Risks and Side Effects of Montelukast

The medication is prescribed to treat shortness of breath and wheezing that often accompanies allergies and asthma. It may also be taken before a workout to prevent issues with breathing during exercise.

Montelukast comes with a range of side effects, including the following:

  • Liver problems as indicated with dark urine, upset stomach, vomiting, yellow eyes or skin, fatigue
  • Memory loss
  • Pancreas issues as indicated with severe stomach or back pain, upset stomach
  • Depression
  • Suicidal thoughts
  • Lack of interest
  • Anxiety
  • Hallucinations
  • Confusion
  • Difficulty sleeping
  • Strange dreams
  • Difficulty speaking
  • Sleepwalking
  • Difficulty controlling movements
  • Seizures
  • Flu-like symptoms
  • Restlessness
  • Chest pain
  • Tingling or numbness
  • Ear pain
  • Swelling

The box has contained warnings of neuropsychiatric events since 2008, but incidents of suicide and other concerns have continued. According to reports from around the world, the incidents have involved children and adolescents. For instance, a study in Netherlands linked the drug to nightmares and depression in children. A government agency in Australia found 167 reports of incidents in minors between 2000 and 2017.

Montelukast is often prescribed for children as well as adults who have asthma episodes induced by exercise. It also helps with allergy rhinitis or hayfever, making it a popular drug for allergy sufferers. According to the FDA’s research, symptoms showed up while the person was taking the medication. In some cases, the symptoms went away once the medication was stopped. In other instances, the symptoms continued or even showed up afterwards.

Several alternatives exist for allergy sufferers, including Flonase and Allegra. These drugs help relieve the symptoms associated with seasonal allergies. For asthma sufferers, there is zafirlukast or Accolate. It has a different active ingredient than Singulair but is similar. It’s available only be prescription. However, it also lists mood changes as a possible side effect of the drug.

Comments

Prescription Drugs

Increased Risk for Opioid Addiction and Relapse with Pandemic

mm

Published

on

Along with the illness, the coronavirus outbreak has many potential secondary concerns. One of these is the likelihood of increased numbers of opioid addicts and relapses.

Addiction Relapses

Most addicts attend some kind of meeting to help them maintain their recovery, whether it be Alcoholics Anonymous, Narcotics Anonymous or another 12-step program. Now that the majority of those meetings and groups have been suspended, the only option is online recovery for a lot of the recovering addicts.

For many of the addicts, online works well. For others, it just isn’t the same. They may not have access to online resources. They often say there is a disconnect online compared to being in the same room with people.

Recovering addicts may feel isolated and suffer from depression along with anxiety because of COVID-19 and the restrictions of social distancing. Even though they understand the need for it, many will be faced with mental health issues. It is these same mental health issues that often lead to addiction in the first place.

Addiction is an isolating situation with people hiding their drug use from others around them. This situation makes it easier for them to continue the behaviors.

A common part of addiction treatment for opioids is methadone and other opioid prescriptions. These medications are given to help prevent the cravings that go along with withdrawal from opioids like heroin. The government has relieved the restrictions of taking the medication daily at a treatment clinic with doctors being able to give prescriptions for 14 or 28 days to take at home.

The problem with this solution is that active addicts may take more than they should and overdose or relapse. They have the entire 28-day supply at their disposal, and they may not be able to withstand the temptation to take extra, especially if they are experiencing anxiety or depression from being alone.

The Risk of Addiction

Those who are prescribed opioid painkillers may face a greater risk as well. While they are monitored for medication use, the anxiety they feel at this pandemic may lead them to experience more physical pain as well. They may self-medicate by increasing the dosage over what was prescribed.

When this happens, people are at a higher risk for developing a dependency on the drugs, which can lead to addiction. With the stay-at-home orders throughout the country, friends and family may not even be aware of changes in mood and behaviors to recognize the indications of addiction.

Risks with COVID-19

Drug users are often a higher risk for developing complications from the virus because of compromised immunity systems and lung damage due to drug abuse. Their withdrawal symptoms can also mask the symptoms of COVID-19, which would lessen the likelihood that they would seek medical attention as quickly as they should.

Medical professionals could also misdiagnose those with COVID-19 as drug withdrawal symptoms. It may take longer for an accurate diagnosis, which could increase the risk of serious health issues or even death.

Comments
Continue Reading

Prescription Drugs

Could Johnson & Johnson Start Testing a Vaccine by Fall?

mm

Published

on

Johnson & Johnson, a major pharmaceutical company, has made plans to begin clinical trials on people of a vaccine for Covid-19 that it has developed. The company suggests it could be ready by September with the first batches of the vaccine ready for public use in an emergency early in 2021.

Hope for a Successful Vaccine

The company stated it had started work on a vaccine for the coronavirus early in January. It is working with BARDA, Biomedical Advance Research and Development Authority, which is a part of the Department of Health and Human Services. The two partners are committing $1 billion for research and development of the vaccine, along with testing.

The chairman of Johnson & Johnson, Alex Gorsky, says his company wants to do what they can to bring a vaccine to the public as quickly as possible. Manufacturing capacity around the world will be expanded if its approved to begin producing the vaccine immediately.

Early tests show the vaccine to be both safe and effective. The hope is that the partnership with BARDA will allow the vaccine to move through testing and approval faster. If approved, the vaccine would be distributed as not-for-profit.

Other Treatments and Vaccines

Another company has also been working on a vaccine. Moderna, a biotech firm based in the US, shipped a test vaccine to the government in February. The first dose has already been administered in a clinical trial in March. It uses material from DNA, which is injected into the body. Immune cells begin to make proteins that mark the virus cells for destruction.

Testing has also begun on a drug which could be used to treat patients with Covid-19. This drug, known as remdesivir, has been used in treatment of Ebola. It was given in a test to a patient who has Covid-19 and is the first drug to be tested for treatment. Other people who have tested positive for the virus will be part of the study.

The study will include volunteers who will either be given the drug or a placebo and monitored. The drug will be given intravenously over a ten-day period. Tests will be taken every other day to determine the amount of the virus in the system. If the drug shows some ability to prevent the growth of the virus, it could reduce the spread of Covid-19.

Experts warn the public not to rely on these early tests to make vaccines available right away. Even if they are viable, it’s expected that it could take at least a year before they would be readily available to the general public. Before this, specific people, such as medical care workers, may have access. Other methods will be necessary to control the spread of the disease in the meantime. However, a treatment for the disease may reduce the death rate. Researchers are working diligently to develop solutions to the coronavirus, but it’s not expected to see dramatic results overnight.

Comments
Continue Reading

Prescription Drugs

Opioid Addiction Patients May Take Medications Home

mm

Published

on

The United States Substance Abuse and Mental Health Services Administration, otherwise known as SMAHSA, has made some significant policy changes for patients who are currently in an opioid treatment program. They are now allowed to take home medication due to the impact of the COVID-19 pandemic.

Treatment Drugs Being Made Available to Recovering Addicts

Patients who are in a treatment program for opioid addiction may have the ability to take home medications, including buprenorphine and methadone. These medications are given to patients as part of the treatment plan. Treatment centers may send home a 28-day supply of the drugs. For those who aren’t quite as stable, they may request up to 14 days of medications.

These medications are given to patients to help wean them off opioid drugs. While the medications contain some opioid ingredients, it is at a lower rate than with heroin and other opioids. It can help the patient stop using drugs without the severe withdrawal symptoms often seen if they stop without the aid of medication. These medicines also help reduce cravings, which can mean the difference in relapse for the patient.

Doctors say it’s critical that patients have access to these medicines with the reality of fewer in-person visits while the pandemic continues. Without the medications, the patients are more likely to regress and return to their former drug use. They also have an increased risk for overdose.

While doctors say there is still some risk for overdose or even abuse of the drugs, the benefits outweigh the disadvantages. They believe it will be a great help to those who are stable in their treatment, but even those who are less stable will benefit, according to many experts.

Another change for drug treatment was announced recently from the Drug Enforcement Administration. Dispensing restrictions are being relaxed while the public health emergency lasts. Instead of just licensed doctors being able to administer or even dispense OUD medications, other professionals will also have that ability. This includes law enforcement and other treatment program staff members as well as members of the national guard.

How Buprenorphine and Methadone Work

Buprenorphine is given to people who are in treatment for opioid use disorder or OUD. It is generally given at the first signs of withdrawal symptoms. If given too soon, it can cause an acute withdrawal. The dosage is adjusted until the person has fewer or no symptoms. A maintenance dose is often continued through treatment.

Methadone is often given during detoxification to lessen withdrawal symptoms. It may also be used as part of maintenance because it helps people stay in treatment. It’s standard practice for the person to go to a treatment center daily to receive the methadone dose to risk them diverting the drug. The medication may be given for months or even years. In fact, some patients continue it throughout their lives to reduce the risk of relapse on heroin or other opioids.

The risk with these medications is in overdose or misuse because they are also opioids. In the time of a pandemic, it causes professionals to change the way they handle the drugs to provide the best care for those who are in treatment for opioid addiction.

Comments
Continue Reading

Trending